46 cases on record
- Cases on record
- 46
- As claimant
- 2
- As respondent
- 44
- Patents held
- Not recorded
- Core tech
- Not recorded
| Case no. | Parties | Role | Court | Filed | Duration | Outcome |
|---|---|---|---|---|---|---|
| 1:26-cv-00265 | Aurobindo Pharma, Ltd. v. Azurity Pharmaceuticals Inc. | Plaintiff | D. Del. | 12 Mar 2026 | 26 d | Voluntary dismissal |
| 2:26-cv-01580 | Axsome Malta, Ltd. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 18 Feb 2026 | 106 d | Dismissed without Prejudice |
| 1:25-cv-01507 | Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 15 Dec 2025 | 116 d | Case Dismissed |
| 2:25-cv-17592 | Axsome Malta, Ltd. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 14 Nov 2025 | 202 d | Dismissed without Prejudice |
| 1:25-cv-00808 | Supernus Pharmaceuticals, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 1 Jul 2025 | 91 d | Voluntary dismissal |
| 2:25-cv-12186 | Supernus Pharmaceuticals, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 26 Jun 2025 | 180 d | Case Consolidated |
| 1:25-cv-00631 | Bayer AG v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 21 May 2025 | 203 d | Voluntary dismissal |
| 2:25-cv-03721 | Axsome Malta, Ltd. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 1 May 2025 | 40 d | Case Consolidated |
| 1:25-cv-00449 | Merck Sharp & Dohme, LLC v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 11 Apr 2025 | 81 d | Consent Judgment |
| 1:25-cv-00422 | AbbVie, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 4 Apr 2025 | 161 d | Case Consolidated |
| 2:25-cv-00643 | Axsome Malta, Ltd. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 21 Jan 2025 | 140 d | Case Consolidated |
| 2:24-cv-11428 | UCB Pharma, Gmbh v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 23 Dec 2024 | 324 d | Consent Judgment |
| 1:24-cv-01331 | Amicus Therapeutics US, LLC v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 6 Dec 2024 | 381 d | Consent Judgment |
| 2:24-cv-10619 | Axsome Malta, Ltd. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 20 Nov 2024 | 202 d | Case Consolidated |
| 3:24-cv-10235 | Intra-cellular Therapies, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 1 Nov 2024 | 70 d | Case Consolidated |
| 1:24-cv-09380 | Supernus Pharmaceuticals, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 23 Sep 2024 | 77 d | Dismissed without Prejudice |
| 3:24-cv-08848 | Intra-cellular Therapies, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 29 Aug 2024 | 589 d | Case Consolidated |
| 2:24-cv-08624 | Axsome Malta, Ltd. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 21 Aug 2024 | 34 d | Case Consolidated |
| 2:24-cv-07511 | Axsome Malta, Ltd. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 2 Jul 2024 | 84 d | Case Consolidated |
| 1:24-cv-00698 | Amicus Therapeutics US, LLC v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 13 Jun 2024 | 557 d | Consent Judgment |
| 3:24-cv-04264 | Intra-cellular Therapies, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 27 Mar 2024 | 303 d | Consent Judgment |
| 2:24-cv-04002 | Axsome Malta, Ltd. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 19 Mar 2024 | 64 d | Case Consolidated |
| 2:24-cv-00309 | Axsome Malta, Ltd. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 18 Jan 2024 | 125 d | Case Consolidated |
| 2:23-cv-23273 | Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 21 Dec 2023 | 503 d | Dismissed without Prejudice |
| 1:23-cv-01372 | Bayer Pharma AG v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 1 Dec 2023 | 161 d | Dismissed with Prejudice |
| 1:23-cv-00877 | Vifor Fresenius Medical Care Renal Pharma, Ltd. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 10 Aug 2023 | 146 d | Dismissed without Prejudice |
| 23-2254 | Aurobindo Pharma, Ltd. v. Merck Sharp & Dohme, B.V. | Plaintiff | Fed. Cir. | 9 Aug 2023 | 582 d | Appeal Dismissed |
| 1:23-cv-00717 | Pfizer, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 30 Jun 2023 | 168 d | Dismissed without Prejudice |
| 23-2089 | Astellas Pharma, Inc. v. Aurobindo Pharma, Ltd. | Defendant | Fed. Cir. | 28 Jun 2023 | 448 d | Case Remanded |
| 1:23-cv-00582 | Vertex Pharmaceuticals, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 26 May 2023 | 189 d | Case Consolidated |
| 1:23-cv-00039 | Merck KGaA v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 13 Jan 2023 | 1116 d | Closed |
| 2:23-cv-00170 | Bausch Health Ireland, Ltd. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 12 Jan 2023 | 291 d | Consent Judgment |
| 1:22-cv-01467 | Amicus Therapeutics US, LLC v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 7 Nov 2022 | 1141 d | Consent Judgment |
| 1:22-cv-01114 | Eli Lilly & Company v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 24 Aug 2022 | 632 d | Dismissed without Prejudice |
| 1:22-cv-00728 | Vertex Pharmaceuticals, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 3 Jun 2022 | 546 d | Appeal Denied |
| 1:22-cv-00377 | MSD International Business, GmbH v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 23 Mar 2022 | 421 d | Consent Judgment |
| 1:22-cv-00227 | Amgen, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 22 Feb 2022 | 630 d | Case Consolidated |
| 1:22-cv-00037 | Amgen, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 10 Jan 2022 | 667 d | Case Dismissed |
| 1:21-cv-01707 | Azurity Pharmaceuticals, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 2 Dec 2021 | 679 d | Dismissed without Prejudice |
| 1:21-cv-00843 | Newron Pharmaceuticals, SPA v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 10 Jun 2021 | 895 d | Dismissed without Prejudice |
| 1:21-cv-00662 | Amgen, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 6 May 2021 | 922 d | Case Dismissed |
| 1:21-cv-00425 | Astellas Pharma, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 24 Mar 2021 | 1867 d | Judgment on the merits for Defendant |
| 1:20-cv-01426 | Novartis, AG v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 23 Oct 2020 | 885 d | Consent Judgment |
| 1:20-cv-00985 | ACADIA Pharmaceuticals, Inc. v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 24 Jul 2020 | 1383 d | Judgment on the merits for Plaintiff |
| 2:20-cv-02576 | Merck Sharp & Dohme, B.V. v. Aurobindo Pharma, Ltd. | Defendant | D.N.J. | 10 Mar 2020 | 1206 d | Judgment on the merits for Plaintiff |
| 1:19-cv-01727 | Allergan v. Aurobindo Pharma, Ltd. | Defendant | D. Del. | 13 Sep 2019 | 1490 d | Case Dismissed |
Source: Patsnap Litigation Data. Cases naming Aurobindo Pharma, Ltd. in the current snapshot.
Run this in Eureka
Patsnap Eureka
See what Aurobindo Pharma is protecting
Portfolio, claim scope and where its coverage is thin. Every answer cites the records behind it.
Analyse this portfolio10,000 free credits to start
Aurobindo Pharma
Map this dispute space
- 01Ranked prior artEvery hit source-linked
- 02Claim-level comparisonAgainst your own product
- 03Legal statusAcross 174 jurisdictions
Disclaimer. This page indexes publicly available court docket data and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Coverage has limits. Records come from a snapshot and may lag live dockets. Sealed filings, amended complaints and post-closure motions may not be reflected, and a case missing from this list is not evidence that it does not exist. Counts on this page describe what the snapshot contains, nothing more.
No characterisation of any party. Appearing on this page means a party is named in a docket record. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, or that any party prevailed.